Clinical trials
Observational Pulmonary Disease, Chronic Obstructive trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 8 |
| Recruiting | 6 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Boehringer Ingelheim | 4 |
| Asan Medical Center | 3 |
| Seoul National University Bundang Hospital | 3 |
| GlaxoSmithKline | 2 |
| Konkuk University Medical Center | 2 |
| Seoul National University | 2 |
| Seoul National University Hospital | 2 |
| Boryung Pharmaceutical Co., Ltd | 1 |
| Chonbuk National University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Disease, Chronic Obstructive | 32 |
| Asthma | 6 |
| Bronchiectasis | 3 |
| Lung Neoplasms | 3 |
| Disease | 2 |
| Lung Diseases, Obstructive | 2 |
| Disease Progression | 1 |
| Dyspnea | 1 |
| Emphysema | 1 |
| Idiopathic Pulmonary Fibrosis | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.